KAITLIN PARSONS: Open Payments
NPI 1225718687 · LAKE MARY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 26 payments from 16 companies in 2025. Trend: 2023 $120 · 2024 $771 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 6 | $168 |
| Axsome Therapeutics, Inc. | 3 | $78 |
| Neurocrine BioSciences, Inc. | 2 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| ABBVIE INC. | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Alkermes, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Bausch Health US, LLC | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
Products named: Azstarys, Auvelity, INGREZZA, CAPLYTA, VRAYLAR, FANAPT, LYBALVI, SPRAVATO.
Industry payments across FL — which companies pay providers there.
